122 related articles for article (PubMed ID: 31190217)
1. The Role of O
Zhang W; Liu M; Li Y; Song S; Li K; Ma Y
Pathol Oncol Res; 2020 Apr; 26(2):1201-1209. PubMed ID: 31190217
[TBL] [Abstract][Full Text] [Related]
2. MGMT Leu84Phe polymorphism contributes to cancer susceptibility: evidence from 44 case-control studies.
Liu J; Zhang R; Chen F; Yu C; Sun Y; Jia C; Zhang L; Salahuddin T; Li X; Lang J; Song X
PLoS One; 2013; 8(9):e75367. PubMed ID: 24086516
[TBL] [Abstract][Full Text] [Related]
3. Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis.
Hu Y; Zhou M; Li K; Zhang K; Kong X; Zheng Y; Li J; Liu L
Tumour Biol; 2014 Mar; 35(3):1715-25. PubMed ID: 24203816
[TBL] [Abstract][Full Text] [Related]
4. The potential role of
Sheng Z; Kang M; Wang H
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30232235
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.
Zhang Z; Wang L; Wei S; Liu Z; Wang LE; Sturgis EM; Wei Q
DNA Repair (Amst); 2010 May; 9(5):558-66. PubMed ID: 20206583
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
[TBL] [Abstract][Full Text] [Related]
7. The role of MGMT polymorphisms rs12917 and rs11016879 in head and neck cancer risk and prognosis.
Kiczmer P; Prawdzic Seńkowska A; Strzelczyk JK; Szydło B; Biernacki K; Osadnik T; Krakowczyk Ł; Ostrowska Z
Acta Biochim Pol; 2018; 65(1):87-92. PubMed ID: 29370316
[TBL] [Abstract][Full Text] [Related]
8. Association of the Promoter Methylation and the rs12917 Polymorphism of MGMT with Formation of DNA Bulky Adducts and the Risk of Lung Cancer in Mexican Mestizo Population.
Martínez-Ramírez OC; Pérez-Morales R; Castro-Hernández C; Gonsebatt ME; Casas-Ávila L; Valdés-Flores M; Petrosyan P; de León-Suárez VP; Rubio J
DNA Cell Biol; 2019 Apr; 38(4):307-313. PubMed ID: 30785779
[TBL] [Abstract][Full Text] [Related]
9. MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study.
Loh YH; Mitrou PN; Bowman R; Wood A; Jeffery H; Luben RN; Lentjes MA; Khaw KT; Rodwell SA
DNA Repair (Amst); 2010 Apr; 9(4):421-8. PubMed ID: 20096652
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of CYP24A1 gene and cancer susceptibility: a meta-analysis including 40640 subjects.
Wang Y; Wang R; Yuan S; Liu X
World J Surg Oncol; 2023 Sep; 21(1):279. PubMed ID: 37670334
[TBL] [Abstract][Full Text] [Related]
11. The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis.
Liu L; Zhai Z; Wang D; Ding Y; Chen X; Wang Q; Shu Z; Wu M; Chen L; He X; Fan D; Pan F; Xing M
Gene; 2021 Feb; 769():145187. PubMed ID: 32998046
[TBL] [Abstract][Full Text] [Related]
12. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
Yang M; Zou Y; Bai Y; Li M
J Orthop Sci; 2015 Jan; 20(1):55-63. PubMed ID: 25270018
[TBL] [Abstract][Full Text] [Related]
13. The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls.
Zhang WB; Zhang JH; Pan ZQ; Yang QS; Liu B
Asian Pac J Cancer Prev; 2012; 13(6):2597-604. PubMed ID: 22938427
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
15. Role of P14 and MGMT gene methylation in hepatocellular carcinomas: a meta-analysis.
Li CC; Yu Z; Cui LH; Piao JM; Liu M
Asian Pac J Cancer Prev; 2014; 15(16):6591-6. PubMed ID: 25169493
[TBL] [Abstract][Full Text] [Related]
16. Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.
Zhang K; Chen X; Zhou J; Yang C; Zhang M; Chao M; Zhang L; Liang C
Oncotarget; 2017 Jul; 8(27):45020-45029. PubMed ID: 28445160
[TBL] [Abstract][Full Text] [Related]
17. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
Huang J; Luo JY; Tan HZ
PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
[TBL] [Abstract][Full Text] [Related]
18. SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.
Kuroiwa-Trzmielina J; Wang F; Rapkins RW; Ward RL; Buchanan DD; Win AK; Clendenning M; Rosty C; Southey MC; Winship IM; Hopper JL; Jenkins MA; Olivier J; Hawkins NJ; Hitchins MP
Clin Cancer Res; 2016 Dec; 22(24):6266-6277. PubMed ID: 27267851
[TBL] [Abstract][Full Text] [Related]
19. Association between MGMT Promoter Methylation and Risk of Breast and Gynecologic Cancers: A Systematic Review and Meta-Analysis.
Chen R; Zheng Y; Zhuo L; Wang S
Sci Rep; 2017 Oct; 7(1):12783. PubMed ID: 28986566
[TBL] [Abstract][Full Text] [Related]
20. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.
FitzGerald LM; Zhao S; Leonardson A; Geybels MS; Kolb S; Lin DW; Wright JL; Eeles R; Kote-Jarai Z; Govindasami K; Giles GG; Southey MC; Schleutker J; Tammela TL; Sipeky C; Penney KL; Stampfer MJ; Gronberg H; Wiklund F; Stattin P; Hugosson J; Karyadi DM; Ostrander EA; Feng Z; Stanford JL
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):228-237. PubMed ID: 29298992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
